Thanks to an app and a small sensor, the Apple Watch show us our real-time glucose levels. Apple has already announced various functions oriented physical activity and health that would have the Apple Watch and lack of more features than the company can reveal a possible keynote, by now we have pretty clear what the smartwatch can not can be done in the field of health. However, it seems that you could win a major medical functionality thanks to the company DexCom.
Source via macrumors
As confirmed a 2 days ago, diabetics using a glucose monitor company DexCom be able to keep a real-time monitoring of their blood sugar levels from Apple’s own screen Watch. To do this, the company released an application for the clock from which will always follow the evolution of their glucose levels.
It is expected that the application is available for the planned launch of Apple Watch the month of April. The app DexCom is responsible for transforming the data obtained by the sensor of the company, which is located just below the skin surface, and transforms it into graphs showing the levels of glucose and updated every 5 minutes thanks to the sensor reading.
As you know, the medical functions of electronic devices must pass strict controls of various regulatory agencies, in the case of the US, it is the FDA. However, because applications do not need this approval, is expected to DexCom can have it ready for next April. Without going any further, the FDA recently confirmed that Apple Watch was not considered a medical but of “general welfare” device.
A small sensor located beneath the surface of the skin send information glucose levels Apple Watch
Glucose monitors conventional blood sampling required from the user, it is necessary to employ a certain needles. Thanks to the non-invasive method of DexCom, diabetics may have a constant control levels without resorting to annoying pricks, although many professionals insist that the latter method is much less reliable. As shown in 9to5Mac, Apple is expected to Watch incorporate in future generations more advanced sensors health, among which may be an integrated meter. For now, the company has published a new job in search of engineers in human anthropometry.
Macrumors.com reported: Previously, the FDA considered glucose monitors and any associated software to be Class III medical devices, meaning they received the highest level of regulatory scrutiny. But the spread of NightScout, the system developed by the group of software engineers, and DexCom’s submission of a separate iPhone app for review prompted the FDA to change course last month.
Via macrumors